Dubai, United Arab Emirates - Saturday, June 1st 2013 [ME NewsWire]
Cellogique Corporation and Croma Princess are happy to announce the expansion of distribution of Croma Princess fillers and mesotherapy to include Saudi Arabia and the United Arab Emirates.
Croma Princess suggests an alternative to plastic surgery with their innovative and sophisticated fillers and mesotherapy. Croma Princess’ revolutionary hyaluronic dermal filler is a sterile, colorless, and homogenized gel implant used to relax facial wrinkles, folds, and scars. The hyaluronic face mesotherapy treatment is a sterile, transparent gel that hydrates and rejuvenates the skin while also making it more elastic. As these treatments are nonsurgical and noninvasive, patients have the ability to resume with daily activity immediately. In addition to these benefits, Croma Princess’ fillers and mesotherapy boast "immediate and natural effects.”
"The distribution of Croma Princess fillers and mesotherapy will give our physician accounts a less invasive and less painful option to surgery to achieve youthful and bright skin with long lasting results,” said Mazen F. Youssef, president and CEO of Cellogique Corporation. Cellogique Corporation has helped to advance many fillers and mesotherapies in the Middle East region by introducing and promoting them in their Obagi MediSpas, and plans to do the same in the distribution of Croma Princess in Saudi Arabia and the United Arab Emirates.
Cellogique Corporation continues to pioneer the world of medical aesthetics and skin health in the Middle East and Turkey by offering the very best cosmetic treatments, procedures, and products available. The newly expanded partnership of Cellogique Corporation and Croma Princess is certain to prove its great potential.
Cellogique Corporation Headquartered in Pittsburgh, Pennsylvania, USA
Regional Office:
www.cellogique.com
www.princessbycroma.com
Contacts
Assaad Atallah
971 4 339 7060
Assaad.atallah@cellogique.ae
|
